Janos Szollosi
Overview
Explore the profile of Janos Szollosi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
1887
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ujlaky-Nagy L, Szollosi J, Vereb G
Cytometry A
. 2025 Mar;
PMID: 40052543
Ligand-induced formation of signaling platforms composed of homo- and/or heterodimers of receptor tyrosine kinases is considered essential for their activation and consequential contribution to the progression of many cancers. Epidermal...
2.
Ujlaky-Nagy L, Szollosi J, Vereb G
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38892166
Pertuzumab (Perjeta), a humanized antibody binding to the dimerization arm of HER2 (Human epidermal growth factor receptor-2), has failed as a monotherapy agent in HER2 overexpressing malignancies. Since the molecular...
3.
Kormos J, Daroczi L, Szollosi J, Matyus L, Jenei A
Curr Protoc
. 2024 May;
4(5):e1045.
PMID: 38717451
The cell surface distribution patterns (clustering) of membrane proteins have been widely investigated in cell biology. Here we describe a novel transmission electron microscopic (TEM) protocol designed to improve the...
4.
Kormos J, Veres A, Imre L, Matyus L, Benko S, Szollosi J, et al.
Cytometry A
. 2023 Aug;
103(12):978-991.
PMID: 37605541
Peptide presentation by MHC class I and MHC class II molecules plays important roles in the regulation of the immune response. One factor in these displays is the density of...
5.
Rebenku I, Lloyd C, Szollosi J, Vereb G
Sci Rep
. 2023 Feb;
13(1):2934.
PMID: 36804608
The actual interaction between signaling species in cellular processes is often more important than their expression levels. Förster resonance energy transfer (FRET) is a popular tool for studying molecular interactions,...
6.
Szabo A, Szollosi J, Nagy P
Curr Protoc
. 2022 Dec;
2(12):e660.
PMID: 36546888
No abstract available.
7.
Szabo A, Szollosi J, Nagy P
Curr Protoc
. 2022 Dec;
2(12):e625.
PMID: 36507547
This unit describes the basic principles of Förster resonance energy transfer (FRET). Beginning with a brief summary of the history of FRET applications, the theory of FRET is introduced in...
8.
Pocsi I, Szigeti Z, Emri T, Boczonadi I, Vereb G, Szollosi J
Appl Microbiol Biotechnol
. 2022 May;
106(11):3895-3912.
PMID: 35599256
While phototoxicity can be a useful therapeutic modality not only for eliminating malignant cells but also in treating fungal infections, mycologists aiming to observe morphological changes or molecular events in...
9.
Guti E, Regdon Z, Sturniolo I, Kiss A, Kovacs K, Demeny M, et al.
Cancer Immunol Immunother
. 2022 Jan;
71(9):2151-2168.
PMID: 35066605
Despite recent advances in the development of novel personalized therapies, breast cancer continues to challenge physicians with resistance to various advanced therapies. The anticancer action of the anti-HER2 antibody, trastuzumab,...
10.
Banko C, Nagy Z, Nagy M, Szeman-Nagy G, Rebenku I, Imre L, et al.
Cancers (Basel)
. 2021 Nov;
13(22).
PMID: 34830806
In cancer therapy, immunogenic cell death eliminates tumor cells more efficiently than conventional apoptosis. During photodynamic therapy (PDT), some photosensitizer (PS) targeting lysosomes divert apoptosis to the immunologically more relevant...